Application
Western blot analysis of KRT13 antibody (N-term) in 293 cell line lysates (35ug/lane). KRT13 (arrow) was detected using the purified Pab.
Application
KRT13 Antibody (N-term) (RB18903) IHC analysis in formalin fixed and paraffin embedded human breast carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the KRT13 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
KRT13 Antibody (N-term) FC analysis of MCF-7 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.